HIF-1a expression and differential effects on survival in patients with oral cavity, larynx, and oropharynx squamous cell carcinomas

被引:13
|
作者
Swartz, Justin E. [1 ]
Wegner, Inge [1 ,2 ]
Noorlag, Rob [3 ]
van Kempen, Pauline M. W. [1 ]
van Es, Robert J. J. [2 ,3 ]
de Bree, Remco [2 ]
Willems, Stefan M. W. [4 ]
机构
[1] Univ Med Ctr Utrecht, Dept Otorhinolaryngol Head & Neck Surg, Heidelberglaan 100, NL-3508 AB Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Head & Neck Surg Oncol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
关键词
head and neck neoplasms; hypoxia; oropharyngeal neoplasms; survival; tumor microenvironment; TISSUE MICROARRAY TECHNOLOGY; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; HYPOXIA; HEAD; RADIOTHERAPY; VALIDATION; HPV; RESISTANCE; PROGNOSIS;
D O I
10.1002/hed.26530
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Hypoxia is a negative prognostic factor in head and neck squamous cell carcinomas. Under hypoxia, the hypoxia-inducible factor (HIF)-1a transcription factor is overexpressed. We investigated whether there were site differences in HIF-1a expression and its effect on patient outcomes per subsite. Design/Method A total of 941 patients with HNSCC in the squamous cell carcinoma of the oropharynx (OPSCC, n = 302), oral cavity (OSCC, n = 391), or larynx (LSCC, n = 248) were included. Expression of HIF-1a in tissue samples was investigated using immunohistochemistry. Overall survival (OS), disease-free survival (DFS), and locoregional control (LRC) were analyzed. Results HIF-1a expression was higher in OSCC than in LSCC and OPSCC. High HIF-1a expression led to worse prognosis in OPSCC (OS P = .029, DFS P = .085) and LSCC (OS P = .041, DFS P = .011) and better in OSCC (OS P = .055, DFS P = .012). There was no association between HIF-1a and LRC. Conclusions High HIF-1a expression is related to poor outcome in OPSCC and LSCC and better outcome in OSCC.
引用
收藏
页码:745 / 756
页数:12
相关论文
共 50 条
  • [41] Prognostic Significance of STING Immunoexpression in Relation to HPV16 Infection in Patients with Squamous Cell Carcinomas of Oral Cavity and Oropharynx
    Biesaga, Beata
    Smolarczyk, Ryszard
    Mucha-Malecka, Anna
    Czapla, Justyna
    Rys, Janusz
    Malecki, Krzysztof
    BIOMEDICINES, 2022, 10 (10)
  • [42] Analysis of HIF-1a and HIF-2a inhibitory compounds in oral cavity and pharyngeal cancer cell lines
    Bogdan Tedeschi, Bianca Barberio
    Henrique, Tiago
    Urbanin Castanhole-Nunes, Marcia Maria
    Kawasaki-Oyama, Rosa Sayoko
    Rodrigues-Fleming, Gabriela Helena
    Simedan Villa, Ana Paula
    Marzochi, Ludimila Leite
    Possebon, Vitoria Scavacini
    Oliveira-Cucolo, Juliana Garcia
    Pavarino, Erika Cristina
    Goloni-Bertollo, Eny Maria
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 269 - 269
  • [43] Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity
    Kim, S. Y.
    Roh, J. -L.
    Kim, J. S.
    Ryu, C. H.
    Lee, J. H.
    Cho, K. -J.
    Choi, S. -H.
    Nam, S. Y.
    EJSO, 2008, 34 (02): : 208 - 215
  • [44] Role of adjuvant radiation in patients with squamous cell carcinomas of the oral cavity
    Maron, Steven Brad
    Rothberg, Bonnie Gould
    Otremba, Michael
    Judson, Benjamin
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity
    Bagutti, C
    Speight, PM
    Watt, FM
    JOURNAL OF PATHOLOGY, 1998, 186 (01): : 8 - 16
  • [46] VEGF expression in cytologic material from squamous cell carcinomas of the oral cavity
    Tatsiou, Z.
    Boglou, K.
    Valeri, R.
    Patrikidou, A.
    Vahtsevanos, K.
    Kehagias, N.
    Destouni, C.
    HISTOPATHOLOGY, 2008, 53 : 90 - 91
  • [47] Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity
    Uraguchi, M
    Morikawa, M
    Shirakawa, M
    Sanada, K
    Imai, K
    JOURNAL OF DENTAL RESEARCH, 2004, 83 (04) : 327 - 332
  • [48] Improvement in Survival of Patients With Oral Cavity Squamous Cell Carcinoma
    Amit, Moran
    Yen, Tzu-Chen
    Liao, Chun-Ta
    Chaturvedi, Pankaj
    Agarwal, Jai Prakash
    Kowalski, Luiz P.
    Ebrahimi, Ardalan
    Clark, Jonathan R.
    Kreppel, Matthias
    Zoeller, Joachim
    Fridman, Eran
    Bolzoni, Villaret A.
    Shah, Jatin P.
    Binenbaum, Yoav
    Patel, Snehal G.
    Gil, Ziv
    CANCER, 2013, 119 (24) : 4242 - 4248
  • [49] PREIRRADATION AND SURGICAL INTERVENTION IN PATIENTS WITH SQUAMOUS-CELL CARCINOMAS OF THE ORAL CAVITY AND THE OROPHARYNX - RESULTS OF A STUDY CONDUCTED FROM 1973 TO 1984
    KNOBBER, D
    SACK, H
    STUTZER, H
    ROSE, KG
    STRAHLENTHERAPIE UND ONKOLOGIE, 1987, 163 (11): : 706 - 713
  • [50] POSTOPERATIVE RADIATION-THERAPY FOR SQUAMOUS-CELL CARCINOMAS OF THE ORAL CAVITY AND OROPHARYNX - IMPACT OF THERAPY ON PATIENTS WITH POSITIVE SURGICAL MARGINS
    ZELEFSKY, MJ
    HARRISON, LB
    FASS, DE
    ARMSTRONG, JG
    SHAH, JP
    STRONG, EW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 25 (01): : 17 - 21